<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>tumor immune microenvironment in PC &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tumor-immune-microenvironment-in-pc/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 29 Oct 2025 12:59:51 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>tumor immune microenvironment in PC &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>m6A Regulators Shape Prostate Cancer Prognosis</title>
		<link>https://bioengineer.org/m6a-regulators-shape-prostate-cancer-prognosis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 29 Oct 2025 12:59:38 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[immunohistochemical analysis in oncology]]></category>
		<category><![CDATA[m6A RNA methylation in prostate cancer]]></category>
		<category><![CDATA[prognostic biomarkers in cancer therapy]]></category>
		<category><![CDATA[tumor immune microenvironment in PC]]></category>
		<category><![CDATA[YTHDF1 and IGFBP2 prognostic biomarkers]]></category>
		<guid isPermaLink="false">https://bioengineer.org/m6a-regulators-shape-prostate-cancer-prognosis/</guid>

					<description><![CDATA[In a groundbreaking study published in BioMedical Engineering OnLine, researchers have unveiled critical insights into the role of m6A RNA methylation regulators within the tumor immune microenvironment of prostate cancer (PC). This study focusses on two pivotal m6A regulatory proteins, YTHDF1 (YTH N6-methyladenosine RNA binding protein 1) and IGFBP2 (insulin-like growth factor binding protein 2), [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">288362</post-id>	</item>
	</channel>
</rss>
